January 26, 2011 — Substituting recombinant tissue plasminogen activator (rt-PA) for heparin once a week as a locking solution in the central venous catheters of patients receiving hemodialysis ...
B. Braun Medical Inc. (B. Braun) announced today the availability of large volume heparin infusion solutions. Based on the new United States Pharmacopeia (USP) standards for heparin products released ...
The FDA approved a taurolidine and heparin (DefenCath) catheter lock solution for reducing the risk of bloodstream infections in patients on dialysis. Approved under a special limited agency pathway, ...
Our own observations have suggested that different commercial preparations of heparin and different concentrations of the same brand of heparin may artificially elevate the blood ammonia concentration ...
This is the first FDA-approved antimicrobial catheter lock solution. The FDA has approved taurolidine plus heparin (DefenCath®) catheter lock solution to reduce catheter-related bloodstream infections ...
Review the side-effects of Preservative-Free Heparin Lock Flush Solution as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking ...
Up-to-date prescription details regarding Preservative-Free Heparin Lock Flush Solution are provided here. Understand it's uses, recommended dosages, its indications, how to take, when to take, when ...
B. Braun Medical has issued a voluntary nationwide recall of Heparin sodium injection solution due to the presence of a heparin-like contaminant.The recall affects 23 Finished Product lots, which were ...
PURPOSE: To determine whether an antibiotic flush solution containing vancomycin, heparin, and ciprofloxacin (VHC) can prevent the majority of line infections. PATIENTS AND METHODS: A prospective ...
THE occurrence of reactions following the use of anticoagulants in the management of patients with myocardial infarction, pulmonary infarction and thrombophlebitis and after vascular surgery has ...
The supply chain in the pharmaceutical industry has always been a prime target for counterfeiters and suppliers delivering substandard and adulterated products. One of the most serious incidents in ...
B. Braun has announced the availability of large volume heparin infusion solutions. P5671, Heparin Sodium (40 U/mL) in 5% Dextrose Injection (500 mL EXCEL Plastic Container) P5771, Heparin Sodium (50 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback